![]() Neurophth Neurophth is a fully integrated genomic medicines company dedicated to seeking to improve lives through the curative potential of gene therapies. | ![]() BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. | ![]() Fortress Biotech Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. | ||
Founding Date | Founding Date 2016 | Founding Date 1986 | Founding Date 2000 | Founding Date 2006 |
Type | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations HQ | Locations Durham, US HQ Hoover, US | Locations Planegg, DE HQ Cambridge, US | Locations New York, US HQ Waltham, US |
Employees | Employees 422% increase | Employees 14040% increase | Employees 147 | Employees 10146% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) N/A | Valuation ($) 55.7 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $63.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $19.1m (FY, 2025) | Cost of goods N/A | Cost of goods $20.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $855.8m (FY, 2025) | Gross profit N/A | Gross profit $42.3m (FY, 2025) |
Net income | Net income N/A | Net income $263.9m (FY, 2025) | Net income N/A | Net income ($32.9m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 60m | Total funding raised $ 1.9m | Total funding raised $ 7m | Total funding raised N/A |

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View company
Proteros biostructures is a company that provides early-stage drug discovery services.
View company
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
View company